Literature DB >> 9514074

Alpha- and beta- alkyl-substituted eicosapentaenoic acids: incorporation into phospholipids and effects on prostaglandin H synthase and 5-lipoxygenase.

L N Larsen1, J Bremer, S Flock, L Skattebøl.   

Abstract

Alpha-ethyl-, alpha-methyl- and beta-methyl eicosapentaenoic acid (EPA) were prepared and their incorporation into cell lipids and effects on eicosanoid synthesis compared with EPA and docosahexaenoic acid (DHA). alpha- and beta-methyl EPA were incorporated into hepatocyte triacylglycerols as efficiently as EPA, whereas lesser amounts were found in phospholipids. alpha-ethyl EPA was not incorporated into phospholipids but small amounts were detected in triacylglycerol. All derivatives inhibited the synthesis of arachidonic acid, although less efficiently than EPA and DHA. The derivatives were poor substrates of prostaglandin H (PGH) synthase and 5-lipoxygenase, and they all inactivated PGH synthase. In isolated platelets, alpha-methyl EPA was a stronger inhibitor of TxB2 production than EPA, alpha-ethyl- and beta-methyl EPA. All derivatives were stronger inducers of peroxisomal beta-oxidation than EPA and DHA. This increased induction probably is a consequence of the blocked mitochondrial beta-oxidation of the derivatives.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9514074     DOI: 10.1016/s0006-2952(97)00497-8

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  3 in total

1.  Sulfur-substituted and alpha-methylated fatty acids as peroxisome proliferator-activated receptor activators.

Authors:  Laila N Larsen; Linda Granlund; Anne Kristin Holmeide; Lars Skattebøl; Hilde Irene Nebb; Jon Bremer
Journal:  Lipids       Date:  2005-01       Impact factor: 1.880

2.  Stable analogs of 13‑hydroxy-9,10-trans-epoxy-(11E)-octadecenoate (13,9-HEL), an oxidized derivative of linoleic acid implicated in the epidermal skin barrier.

Authors:  Gregory S Keyes; Kristen Maiden; Christopher E Ramsden
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2021-10-24       Impact factor: 4.006

3.  Dual targeting of hepatic fibrosis and atherogenesis by icosabutate, an engineered eicosapentaenoic acid derivative.

Authors:  Geurt Stokman; Anita M van den Hoek; Ditte Denker Thorbekk; Elsbet J Pieterman; Sanne Skovgård Veidal; Brittany Basta; Marta Iruarrizaga-Lejarreta; José W van der Hoorn; Lars Verschuren; Jimmy F P Berbée; Patrick C N Rensen; Tore Skjaeret; Cristina Alonso; Michael Feigh; John J P Kastelein; Scott L Friedman; Hans M G Princen; David A Fraser
Journal:  Liver Int       Date:  2020-11       Impact factor: 5.828

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.